ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

PYC Physiomics Plc

1.55
0.00 (0.00%)
24 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Physiomics Plc LSE:PYC London Ordinary Share GB00BDR6W943 ORD 0.4P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1.55 1.40 1.70 0.00 07:40:09
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Pharmaceutical Preparations 597k -477k -0.0035 -4.43 2.1M

Physiomics PLC Director Dealing (0902Z)

12/12/2017 10:17am

UK Regulatory


Physiomics (LSE:PYC)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Physiomics Charts.

TIDMPYC

RNS Number : 0902Z

Physiomics PLC

12 December 2017

12(th) December 2017

Physiomics plc

("Physiomics") or ("the Company")

Director Dealing

The Company announces that it received notice today that the following Directors sold the following number of ordinary shares in the Company at the following prices per share:

 
 Director             Number of shares   Sale price per 
                       sold               share 
-------------------  -----------------  --------------- 
 Dr J Millen, CEO     240,000            8.3p 
-------------------  -----------------  --------------- 
 Dr C Chassagnole, 
  COO                 600,000            8.3p 
-------------------  -----------------  --------------- 
 

Following the sales of shares, the total holdings of each Director of the Company will be as follows:

   Dr Paul Harper                   525,707 
   Dr Jim Millen                     444,641 
   Dr Christophe Chassagnole   417,008 

The total number of shares in issue remains 58,785,394 Ordinary Shares with voting rights attached (one vote per Share). There are no Shares held in treasury. This total voting rights figure may be used by shareholders as the denominator for the calculations by which they will determine whether they are required to notify their interests in, or a change to their interest in, Physiomics under the Disclosure and Transparency Rules.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 
 1    Details of the person discharging managerial responsibilities/person closely associated 
---  ----------------------------------------------------------------------------------------------- 
 a)   Name                                                                  James Millen 
---  --------------------------------------------------------------------  ------------------------- 
 2    Reason for the notification 
---  ----------------------------------------------------------------------------------------------- 
 a)   Position/status                                                       Director, CEO 
---  --------------------------------------------------------------------  ------------------------- 
 b)   Initial notification/ Amendment                                       Initial notification 
---  --------------------------------------------------------------------  ------------------------- 
 3    Details of the issuer, emission allowance market participant, auction platform, auctioneer 
       or auction monitor 
---  ----------------------------------------------------------------------------------------------- 
 a)   Name                                                                  Physiomics plc 
---  --------------------------------------------------------------------  ------------------------- 
 b)   LEI                                                                   213800A71DSZ6ABMTQ91 
---  --------------------------------------------------------------------  ------------------------- 
 4    Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; and (iv) each place where transactions have been 
       conducted 
---  ----------------------------------------------------------------------------------------------- 
 a)   Description of the financial instrument, type of instrument           Ordinary share 
 
       Identification code 
                                                                             GB00BDR6W943 
---  --------------------------------------------------------------------  ------------------------- 
 b)   Nature of the transaction                                             Disposal of shares 
---  --------------------------------------------------------------------  ------------------------- 
 c)   Price(s) and volume(s)                                                 Price(s)   Volume(s) 
                                                                             ---------  ---------- 
                                                                              8.3p       240,000 
                                                                             ---------  ---------- 
---  --------------------------------------------------------------------  ------------------------- 
 d)    Aggregated information 
         *    Aggregated volume                                               240,000 
                                                                              At 8.3p per share 
 
         *    Price 
---  --------------------------------------------------------------------  ------------------------- 
 e)   Date of the transaction                                               12-12-2017 
---  --------------------------------------------------------------------  ------------------------- 
 f)   Place of the transaction                                              XLON, AIM 
---  --------------------------------------------------------------------  ------------------------- 
 

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 
 1    Details of the person discharging managerial responsibilities/person closely associated 
---  ----------------------------------------------------------------------------------------------- 
 a)   Name                                                                  Christophe Chassagnole 
---  --------------------------------------------------------------------  ------------------------- 
 2    Reason for the notification 
---  ----------------------------------------------------------------------------------------------- 
 a)   Position/status                                                       Director, COO 
---  --------------------------------------------------------------------  ------------------------- 
 b)   Initial notification/ Amendment                                       Initial notification 
---  --------------------------------------------------------------------  ------------------------- 
 3    Details of the issuer, emission allowance market participant, auction platform, auctioneer 
       or auction monitor 
---  ----------------------------------------------------------------------------------------------- 
 a)   Name                                                                  Physiomics plc 
---  --------------------------------------------------------------------  ------------------------- 
 b)   LEI                                                                   213800A71DSZ6ABMTQ91 
---  --------------------------------------------------------------------  ------------------------- 
 4    Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) 
       each type of transaction; (iii) each date; and (iv) each place where transactions have been 
       conducted 
---  ----------------------------------------------------------------------------------------------- 
 a)   Description of the financial instrument, type of instrument           Ordinary share 
 
       Identification code 
                                                                             GB00BDR6W943 
---  --------------------------------------------------------------------  ------------------------- 
 b)   Nature of the transaction                                             Disposal of shares 
---  --------------------------------------------------------------------  ------------------------- 
 c)   Price(s) and volume(s)                                                 Price(s)   Volume(s) 
                                                                             ---------  ---------- 
                                                                              8.3p       600,000 
                                                                             ---------  ---------- 
---  --------------------------------------------------------------------  ------------------------- 
 d)    Aggregated information 
         *    Aggregated volume                                               600,000 
                                                                              At 8.3p 
 
         *    Price 
---  --------------------------------------------------------------------  ------------------------- 
 e)   Date of the transaction                                               12-12-2017 
---  --------------------------------------------------------------------  ------------------------- 
 f)   Place of the transaction                                              XLON, AIM 
---  --------------------------------------------------------------------  ------------------------- 
 

Enquiries:

Physiomics plc

Dr Jim Millen, CEO

+44 (0)1865 784 980

WH Ireland Limited (nomad)

Katy Mitchell, James Sinclair-Ford

+44 (0) 161 832 2174

Hybridan LLP (broker)

Claire Louise Noyce

+44 (0) 203 764 2341

The information contained within this announcement is deemed by the Company to constitute inside information under the Market Abuse Regulation (EU) No. 596/2014.

This information is provided by RNS

The company news service from the London Stock Exchange

END

DSHTTBMTMBBBBIR

(END) Dow Jones Newswires

December 12, 2017 05:17 ET (10:17 GMT)

1 Year Physiomics Chart

1 Year Physiomics Chart

1 Month Physiomics Chart

1 Month Physiomics Chart

Your Recent History

Delayed Upgrade Clock